Answer:
d. Measure thyroid-stimulating hormone level
Explanation:
The most suitable next step in management of this patient is to measure a thyroid stimulating hormone, or thyrotropin level.
This patient's apparent treatment refractory dyslipidemia is most likely contributed by undiagnosed thyroid disease. Despite sticking to the treatment with atorvastatin, his LDL AND total cholesterol are raised.
Additionally, there are some clinical signals that give an idea about the diagnosis of hypothyroidism especially fatigue and constipation.
Hypothyroidism is concerned with and is a very common secondary cause of dyslipidemia and thyrotropin level measures are indicated.
Hyperlipidemia may show better results to thyroid stimulating hormone.
Hence option D is the right answer.
Sterilization controls the microbial in this world
Carbon and fluorine combine covalently to form a binary compound. the formula of the compound with the name carbon tetrafluoride is CF4.
